Tonix Pharmaceuticals Introduces TONMYA™ for Fibromyalgia
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) has announced the commercial availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets), marking a significant milestone in the treatment of fibromyalgia. This product is now available at pharmacies across the United States through prescription.
A Historic Advancement in Fibromyalgia Treatment
The FDA has approved TONMYA as the first new fibromyalgia treatment in over 15 years. This innovative, non-opioid analgesic is designed for once-daily use at bedtime, providing a unique solution for adults grappling with the debilitating symptoms of fibromyalgia, including widespread pain.
“This availability of TONMYA is a groundbreaking moment for Tonix and the estimated 10 million individuals living with fibromyalgia. Our non-opioid approach addresses the core symptoms experienced by these patients, offering a much-needed alternative,” stated Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals.
Clinical Trial Success and Efficacy
The effectiveness of TONMYA was demonstrated in the Phase 3 clinical trial known as RESILIENT, which produced promising results regarding pain management. The study focused on primary endpoints related to pain reduction as well as secondary endpoints measuring sleep quality, fatigue, and overall patient experience. The data from these trials revealed that participants treated with TONMYA experienced a clinically meaningful reduction in pain compared to those given a placebo.
Practical Insights from Healthcare Professionals
Experts in the field have expressed optimism regarding this new treatment. According to Dr. Andrea L. Chadwick from The University of Kansas Health System, “Many patients with fibromyalgia have suffered due to limited treatment options that provide inadequate relief. The introduction of TONMYA is a significant breakthrough, targeting neurotransmitters involved in fibromyalgia.”
Sharon Waldrop, a fibromyalgia advocate and founder of the Fibromyalgia Association, echoed this enthusiasm, stating, “The launch of TONMYA provides renewed hope for our community, marking a critical step forward in the management of fibromyalgia.”
Understanding Fibromyalgia
Fibromyalgia is a complex and chronic pain disorder that disrupts the normal functioning of the central nervous system, leading to amplified pain signaling. Affecting approximately 10 million adults in the United States, it often impacts women disproportionately, with around 80% of affected individuals being women. Symptoms extend beyond chronic pain to include fatigue, disrupted sleep, cognitive issues, and emotional challenges.
Patient Experience with TONMYA
In clinical trials involving over 1,400 patients, TONMYA was generally well tolerated, with common side effects being mild and manageable. The most frequently reported adverse reactions included oral hypoesthesia, dry mouth, and somnolence, with the majority of patients expressing satisfaction with the treatment.
Future Directions for Tonix Pharmaceuticals
As a fully integrated biotechnology company, Tonix is committed to expanding its portfolio focused on central nervous system disorders and other medical needs. The successful launch of TONMYA could pave the way for further innovations in pain management and related treatments. Tonix operates a state-of-the-art research facility dedicated to infectious diseases and thoroughly invests in developing advanced therapeutics.
Frequently Asked Questions
What is TONMYA?
TONMYA is an FDA-approved medication used for treating fibromyalgia, available as sublingual tablets taken daily at bedtime.
Who should consider using TONMYA?
Adults suffering from fibromyalgia symptoms can talk to their healthcare provider about the suitability of TONMYA as a treatment option.
What are the common side effects of TONMYA?
Common side effects reported include oral hypoesthesia, dry mouth, drowsiness, and oral discomfort. Most patients tolerated the medication well.
How does TONMYA work?
TONMYA works by targeting neurotransmitters linked to fibromyalgia, thereby helping to alleviate widespread pain and improve sleep quality.
Where can I obtain TONMYA?
TONMYA is available by prescription and can be ordered at pharmacies nationwide.
